160 related articles for article (PubMed ID: 6894424)
41. The relationship of growth hormone to 1,25-dihydroxyvitamin D3 in intestinal calcium transport.
Yeh JK; Aloia JF
Metab Bone Dis Relat Res; 1981; 3(1):47-9. PubMed ID: 6894959
[TBL] [Abstract][Full Text] [Related]
42. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
Norman AW; Sergeev IN; Bishop JE; Okamura WH
Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333
[TBL] [Abstract][Full Text] [Related]
43. Transplacental effects of 1,25-dihydroxycholecalciferol and of 24,25-dihydroxycholecalciferol on the limb skeleton of fetuses and offspring rats.
Zusman I; Hirsh BE; Edelstein S; Ornoy A
Acta Anat (Basel); 1981; 111(4):343-51. PubMed ID: 6976671
[TBL] [Abstract][Full Text] [Related]
44. Developmental changes in the responsiveness of rat kidney to vitamin D metabolites.
Sömjen D; Weisman Y; Berger E; Earon Y; Kaye AM; Binderman I
Endocrinology; 1986 Jan; 118(1):354-9. PubMed ID: 3000745
[TBL] [Abstract][Full Text] [Related]
45. The influence of 1 alpha,25- and 24(R),25-dihydroxyvitamin D3 on bone constituents during early mineralization in the rat.
Vukicević S; Bagi C; Vujicić G; Krempien B; Stavljenić A; Herak M
Bone Miner; 1986 Oct; 1(5):383-96. PubMed ID: 3509782
[TBL] [Abstract][Full Text] [Related]
46. Effect of 1,25-dihydroxyvitamin D3 on the renal handling of Pi in thyroparathyroidectomized rats.
Bonjour JP; Preston C; Fleisch H
J Clin Invest; 1977 Dec; 60(6):1419-28. PubMed ID: 915006
[TBL] [Abstract][Full Text] [Related]
47. Intestinal and metabolic effect of 1,25-dihydroxyvitamin D3 in normal adult rat.
Lee DB; Walling MM; Levine BS; Gafter U; Silis V; Hodsman A; Coburn JW
Am J Physiol; 1981 Jan; 240(1):G90-6. PubMed ID: 7457613
[TBL] [Abstract][Full Text] [Related]
48. The effects of 1,25-dihydroxycholecalciferol on embryonic bone in vitro: a biochemical and histological study.
Herrmann-Erlee MP; Gaillard PJ
Calcif Tissue Res; 1978 May; 25(2):111-8. PubMed ID: 208719
[TBL] [Abstract][Full Text] [Related]
49. 24,25(OH)2D3, bone formation, and bone resorption in vitamin D-deficient, azotemic rats.
Goodman WG; Baylink DJ; Sherrard DJ
Calcif Tissue Int; 1984 Mar; 36(2):206-13. PubMed ID: 6430503
[TBL] [Abstract][Full Text] [Related]
50. Interaction between calcium and 1,25-dihydroxyvitamin D3 in the regulation of preproparathyroid hormone and vitamin D receptor messenger ribonucleic acid in avian parathyroids.
Russell J; Bar A; Sherwood LM; Hurwitz S
Endocrinology; 1993 Jun; 132(6):2639-44. PubMed ID: 8389284
[TBL] [Abstract][Full Text] [Related]
51. Enhancement of osteoinduction by vitamin D metabolites in rachitic host rats.
Atkin I; Dean DD; Muniz OE; Agundez A; Castiglione G; Cohen G; Howell DS; Ornoy A
J Bone Miner Res; 1992 Aug; 7(8):863-75. PubMed ID: 1442201
[TBL] [Abstract][Full Text] [Related]
52. [Effect of 1,25-dihydroxycholecalciferol and 24,25-dihydroxycholecalciferol on calcium homeostasis in rats treated with hydrocortisone].
Karatabanova NA; Sokolova SV; Bogoslovskiĭ NA; Spirichev VB
Vopr Med Khim; 1985; 31(3):112-6. PubMed ID: 3875180
[TBL] [Abstract][Full Text] [Related]
53. Resistance to parathyroid hormone in renal failure: role of vitamin D metabolites.
Somerville PJ; Kaye M
Kidney Int; 1978 Sep; 14(3):245-54. PubMed ID: 723151
[TBL] [Abstract][Full Text] [Related]
54. Short-term effects of vitamin D3 and 1,25-dihydroxyvitamin D3 on osteomalacia in uremic rats fed a low calcium-low-phosphorus diet.
Weisbrode SE
Am J Pathol; 1981 Jul; 104(1):35-40. PubMed ID: 6266257
[TBL] [Abstract][Full Text] [Related]
55. Effect of growth hormone on the metabolism of 25-hydroxycholecalciferol in hypophysectomized rats on a diet without vitamin D and low in calcium.
Pavlovitch H; Fontaine O; Balsan S
J Endocrinol; 1978 Dec; 79(3):277-81. PubMed ID: 744925
[TBL] [Abstract][Full Text] [Related]
56. In vivo studies in chicks and rats of bone calcium mobilization by 1 alpha,25-dihydroxycholecalciferol (calcitriol) and its congeners.
Boris A; Hurley JF; Trmal T
J Nutr; 1979 Oct; 109(10):1772-8. PubMed ID: 226665
[No Abstract] [Full Text] [Related]
57. Chronic administration of 1,25-dihydroxyvitamin D3: increased bone but impaired mineralization.
Wronski TJ; Halloran BP; Bikle DD; Globus RK; Morey-Holton ER
Endocrinology; 1986 Dec; 119(6):2580-5. PubMed ID: 3780540
[TBL] [Abstract][Full Text] [Related]
58. Influence of 1 alpha-hydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 on experimentally induced heterotopic ossification in rats.
Lindholm TC; Lindholm TS; Nilsson OS; Sjökvist G
Scand J Rheumatol; 1986; 15(1):68-74. PubMed ID: 3485817
[TBL] [Abstract][Full Text] [Related]
59. Hypoparathyroidism during pregnancy: treatment with calcitriol.
Salle BL; Berthezene F; Glorieux FH; Delvin EE; Berland M; David L; Varenne JP; Putet G
J Clin Endocrinol Metab; 1981 Apr; 52(4):810-3. PubMed ID: 6894151
[TBL] [Abstract][Full Text] [Related]
60. Effects of 1,25-dihydroxycholecalciferol on serum calcium, phosphate, and immunoreactive parathyroid hormone in dogs.
Oldham SB; Smith R; Hartenbower DL; Henry HL
Adv Exp Med Biol; 1978; 103():509-16. PubMed ID: 717120
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
